Mochi Health Slashes GLP-1 Prices

Mochi Health has recently enhanced its weight loss treatment offerings by implementing dose-based pricing for GLP-1 medications and introducing an integrated blood-testing service called Mochi Labs.

This new pricing model reduces the initial cost for many patients, with compounded semaglutide starting at $60 per month and compounded tirzepatide at $90 per month. Membership, which includes unlimited provider visits and clinical support, begins at $79 for the first month, with medication costs billed separately.

The Mochi Labs service allows patients to order bloodwork, including core health panels like cholesterol and A1C testing, starting at $26. Results are delivered directly to the patient portal, streamlining the monitoring process for individuals undergoing GLP-1 treatment.

These updates aim to address common concerns regarding the cost and ongoing medical oversight of GLP-1 therapies. By offering lower starting prices and convenient lab testing, Mochi Health positions itself as a comprehensive and accessible weight management solution. The laboratory service is available in most states, excluding New York, New Jersey, Rhode Island, and Hawaii.